Inverse Relationship between Serum Levels of Interleukin-1β and Testosterone in Men with Stable Coronary Artery Disease
The DOI matches its Crossref record.
Abstract
OBJECTIVES: To examine the relationship between serum levels of inflammatory cytokines and testosterone in men with stable coronary artery disease (CAD). Evidence supports a beneficial effect of testosterone upon objective measures of myocardial ischaemia in men with CAD, and in animal models of atherosclerosis. Inflammatory cytokines are involved in many stages of the atherosclerotic process, however, the effect of testosterone upon inflammatory cytokines within the cardiovascular system is largely unknown. METHODS: Serum was collected from 69 men (59+/-1 years) having >75% occlusion of 1, 2, or 3 coronary arteries. Levels of total testosterone (TT), bioavailable testosterone (BT), tumour necrosis factor-alpha (TNFalpha), interleukin (IL)-1-beta (IL-1beta), IL-6 and IL-10 were measured and analysis made between men with 1, 2, or 3 vessel CAD, and between men with hypogonadal, borderline hypogonadal and eugonadal serum levels of testosterone. RESULTS: In patients with 1, 2, or 3 vessel CAD, significant stepwise increases were observed in levels of IL-1beta: 0.16+/-0.03, 0.22+/-0.06, and 0.41+/-0.08 pg/ml (p=0.035), and IL-10: 0.93+/-0.11, 1.17+/-0.14, and 2.94+/-0.65 pg/ml (p=0.008). A significant stepwise increase in levels of IL-1beta was also observed in eugonadal, borderline hypogonadal, and hypogonadal men: 0.19+/-0.05, 0.29+/-0.05, and 0.46+/-0.13 pg/ml (p=0.047). CONCLUSION: Consequently this data implicates IL-1beta and IL-10 in the pathogenesis of CAD and suggests that testosterone may regulate IL-1beta activity in men with CAD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Testosterone is an important regulator of body composition with ageing, as it increases muscle and bone mass, increases IGF1 levels, decreases inflammatory markers405 and alters biomarkers of bone turnover in adults with hypogonadism.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [405]
In the citing paper
“In obesity, the serum levels of testosterone decrease in response to increased aromatase activity, which converts testosterone to estradiol aromatization, resulting in hypogonadotropic hypogonadism [46].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [46]
Citations
Cited by
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382
Testosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 577
Self-citationKelly, D. M., & Jones, T. H. (2015) · Obesity Reviews · doi:10.1111/obr.12282 · Cited by 487
Self-citationHong, S.-H., & Choi, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020494 · Cited by 390
Muraleedharan, V., Marsh, H., Kapoor, D., Channer, K. S., & Jones, T. H. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0321 · Cited by 389
Self-citationTestosterone deficiency, insulin resistance and the metabolic syndrome
Zitzmann, M. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.212 · Cited by 352
Kalinchenko, S. Y., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Giltay, E. J., & Saad, F. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03845.x · Cited by 341
Novel insights in SHBG regulation and clinical implications
Simó, R., Sáez-López, C., Barbosa-Desongles, A., Hernández, C., & Selva, D. M. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.001 · Cited by 335
The relationship between circulating testosterone and inflammatory cytokines in men
Mohamad, N.-V., Wong, S. K., Wan Hasan, W. N., Jolly, J. J., Nur-Farhana, M. F., Ima-Nirwana, S., & Chin, K.-Y. (2019) · The Aging Male · doi:10.1080/13685538.2018.1482487 · Cited by 312
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men
Lunenfeld, B., Mskhalaya, G., Zitzmann, M., Arver, S., Kalinchenko, S., Tishova, Y., & Morgentaler, A. (2015) · The Aging Male · doi:10.3109/13685538.2015.1004049 · Cited by 312
Testosterone: a vascular hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0582 · Cited by 293
“…beneficial effects of androgen supplementation on atherosclerosis in males, with evidence for AR-dependent and -independent actions, resulting in the underlying mechanisms being difficult to elucidate (Bruck et al. 1997, Alexandersen et al. 1999, Nathan et al. 2001, Nettleship et al. 2007a).”
BackgroundInfluentialSelf-citationTraish, A. M., Miner, M. M., Morgentaler, A., & Zitzmann, M. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.12.027 · Cited by 202
Testosterone deficiency: a risk factor for cardiovascular disease?
Jones, T. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.03.002 · Cited by 194
Self-citationCommentary: Testosterone, a key hormone in the context of COVID-19 pandemic
Pozzilli, P., & Lenzi, A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154252 · Cited by 161
The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
Jones, T. H., & Saad, F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.016 · Cited by 167
Self-citationTraish, A. M., Bolaños, J., Nair, S., Saad, F., & Morgentaler, A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120549 · Cited by 172
Saad, F., Aversa, A., M. Isidori, A., & J. Gooren, L. (2012) · Current Diabetes Reviews · doi:10.2174/157339912799424573 · Cited by 148
“In elderly men, an inverse relationship between plasma T and inflammatory markers was observed [49].”
BackgroundTestosterone deficiency in the aging male
McBride, J. A., Carson, C. C., & Coward, R. M. (2016) · Therapeutic Advances in Urology · doi:10.1177/1756287215612961 · Cited by 106
Hotta, Y., Kataoka, T., & Kimura, K. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2019.02.005 · Cited by 100
Review: Testosterone and the metabolic syndrome
Muraleedharan, V., & Jones, T. H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810390258 · Cited by 111
Self-citationSharma, R., Oni, O. A., Gupta, K., Sharma, M., Sharma, R., Singh, V., Parashara, D., Surineni, K., Dawn, B., Chen, G., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004880 · Cited by 90
Androgen deficiency and atherosclerosis: The lipid link
Traish, A. M., Abdou, R. Y., & Kypreos, K. E. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.09.003 · Cited by 89
Testosterone and Coronary Artery Disease
Nettleship, J. E., Jones, R. D., Channer, K. S., & Jones, T. H. (2008) · Frontiers of Hormone Research · doi:10.1159/000176047 · Cited by 83
Self-citationSimó, R., Barbosa-Desongles, A., Hernandez, C., & Selva, D. M. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1152 · Cited by 82
“Several observational studies have reported an inverse relationship between serum levels of IL1 and testosterone, which might be explained by an impairment of the hypothalamic-pituitary-gonadal axis induced by IL1 (34, 35).”
BackgroundMuraleedharan, V., & Jones, T. H. (2014) · Clinical Endocrinology · doi:10.1111/cen.12503 · Cited by 85
Self-citationRecommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men
Lunenfeld, B., Mskhalaya, G. J., Zitzmann, M., Corona, G., Arver, S., Kalinchenko, S. Y., Tishova, Y. A., & Morgentaler, A. (2021) · The Aging Male · doi:10.1080/13685538.2021.1962840 · Cited by 69
Do low testosterone levels contribute to the pathogenesis of asthma?
Cangüven, Ö., & Albayrak, S. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.01.006 · Cited by 58
“A significant stepwise increase in levels of IL1beta was seen when the patients’ testosterone reach hypogonadic levels [17].”
BackgroundAzevedo, V. Z., Silaghi, C. A., Maurel, T., Silaghi, H., Ratziu, V., & Pais, R. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.774030 · Cited by 68
“testosterone aromatization to estradiol, causing hypogonadism (146).”
Farias, J. M., Tinetti, M., Khoury, M. C., & Umpierrez, G. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2585 · Cited by 52
Jim, H., Park, J. Y., Permuth‐Wey, J., Rincon, M., Phillips, K. M., Small, B. J., & Jacobsen, P. B. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.03.001 · Cited by 47
“Relative to eugonadal men, hypogonadal men evidence elevated serum levels of inflammatory cytokines, including IL-1B, IL-6, and TNF-a (Khosla et al., 2002; Nettleship et al., 2007).”
Mushannen, T., Cortez, P., Stanford, F. C., & Singhal, V. (2019) · Children · doi:10.3390/children6050063 · Cited by 50
Saad, F. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2354 · Cited by 39
Eslami, V., Katz, M. J., White, R. S., Sundermann, E. E., Jiang, J. M., Ezzati, A., & Lipton, R. B. (2016) · Gerontology · doi:10.1159/000446651 · Cited by 44
Nasser, M., Haider, A., Saad, F., Kurtz, W., Doros, G. D., Fijak, M., Vignozzi, L., & Gooren, L. J. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0014 · Cited by 42
Hammad, A. M., Ibrahim, Y. A., Khdair, S. I., Hall, F. S., Alfaraj, M., Jarrar, Y. B., & Abed, A. F. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113475 · Cited by 34
Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
Hwang, K., & Miner, M. M. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.146968 · Cited by 37
Saad, F., Haider, A., & Gooren, L. J. (2015) · Andrologia · doi:10.1111/and.12452 · Cited by 27
“A whole range of studies testify now to the anti-inflammatory effect of testosterone (Malkin et al., 2004; Zitzmann et al., 2005; Guler et al., 2006; Kapoor et al., 2007; Nettleship et al., 2007; Corrales et al., 2009; Tengstrand et al., 2009; Kaplan et al., 2010).”
BackgroundTestosterone inhibits aneurysm formation and vascular inflammation in male mice
Son, B., Kojima, T., Ogawa, S., & Akishita, M. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0646 · Cited by 30
Barbosa, L. P., Aguiar, S. D. S., Santos, P. A., Rosa, T. D. S., Maciel, L. A., Deus, L. A., Neves, R. V. P., Leite, P. L. D. A., Gutierrez, S. D., Sousa, C. V., et al. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111407 · Cited by 28
“Some studies have shown a significant inverse relationship between hormonal levels, especially testosterone, with inflammation markers (Bobjer et al. 2013; Maggio et al. 2006; Nettleship et al. 2007).”
BackgroundCrucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity
Lőrincz, H., Somodi, S., Ratku, B., Harangi, M., & Paragh, G. (2023) · Metabolites · doi:10.3390/metabo13020270 · Cited by 28
Molina‐Vega, M., Asenjo‐Plaza, M., García‐Ruiz, M. C., Varea‐Marineto, E., Casal‐Nievas, N., Álvarez‐Millán, J. J., Cabezas-Sánchez, P., Cardona, F., Queipo‐Ortuño, M. I., Castellano‐Castillo, D., et al. (2019) · Obesity · doi:10.1002/oby.22579 · Cited by 23
“Furthermore, subnormal testosterone concentrations have been related to the severity of coronary heart disease (31), and prospective studies have shown that individuals with lower testosterone levels have increased risk of atrial fibrillation, cerebrovascular disease, and cardiovascular death (32).”
BackgroundMen’s Health in Primary Care: An Emerging Paradigm of Sexual Function and Cardiometabolic Risk
Miner, M. M. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.09.003 · Cited by 23
Marcelli, M., & Mediwala, S. N. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001233 · Cited by 25
SARS-CoV-2 effects in the genitourinary system and prospects of sex hormone therapy
Liu, K., Chen, X., Ren, X., Wu, Y., Ren, S., & Qin, C. (2020) · Asian journal of urology · doi:10.1016/j.ajur.2020.11.004 · Cited by 24
“In addition, the relationship between an accumulation of proinflammatory factors and a decline in testosterone was frequently observed in elderly people [51] and in patients with stable coronary heart disease [52].”
Androgens and atrial fibrillation: Friends or foes?
Liu, T., Shehata, M. M., Li, G., & Wang, X. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.02.039 · Cited by 17
Androgens, Endometriosis and Pain
Evans, S. F., Hull, M. L., Hutchinson, M. R., & Rolan, P. E. (2021) · Frontiers in Reproductive Health · doi:10.3389/frph.2021.792920 · Cited by 14
“In the majority of studies in men, low levels of testosterone were associated with an increase in IL-1β, IL6, and TNF-α, a reduction in the anti-inflammatory cytokine IL-10, and an increase in body fat mass (19, 20).”
BackgroundNovel androgen therapies including selective androgen receptor modulators
Kang, J., Chen, R., Tharakan, T., & Minhas, S. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101686 · Cited by 16
COVID ‐19: biological factors in men's vulnerability
White, A., & Kirby, M. (2020) · Trends in Urology & Men s Health · doi:10.1002/tre.757 · Cited by 16
Jankowska, E. A., Tkaczyszyn, M., Kalicińska, E., Banasiak, W., & Ponikowski, P. P. (2014) · Kardiologia Polska · doi:10.5603/kp.a2014.0025 · Cited by 13
“Adverse clinical and prognostic consequences of testosterone deficiency in men; ANS — autonomic nervous system; references: 1 [139–142], 2 [143], 3 [144–149], 4 [150], 5 [151–159], 6 [160–163], 7 [160, 164, 165], 8 [46, 53], 9 [166–170], 10 [171], 11 [172, 173], 12 [174, 175], 13 [176, 177]”
Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
Kalra, S., Bhattacharya, S., & Kalhan, A. (2020) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2020.16.2.88 · Cited by 15
“Another study of 69 men with stable coronary artery disease revealed a significant inverse correlation between testosterone and IL-1β across the spectrum of eugonadal, borderline hypogonadal and hypogonadal men.(43) Testosterone is also documented to protect murine models from severe influenza by attenuating the proin…”
BackgroundBlackwell, K., Blackwell, M., & Blackwell, T. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01935-1 · Cited by 13
The role of androgens in migraine pathophysiology
Dourson, A. J., Darken, R. S., Baranski, T., Gereau, R. W., Ross, W. T., & Nahman‐Averbuch, H. (2024) · Neurobiology of Pain · doi:10.1016/j.ynpai.2024.100171 · Cited by 10
“In men, higher testosterone levels relate to higher levels of the anti-inflammatory cytokine IL-10 and lower levels of pro-inflammatory cytokines such as IL-1 β , IL-6, and TNF-α (Maggio et al., 2005, Nettleship et al., 2007, Mohamad et al., 2019).”
BackgroundHaider, A., Kurtz, W., Giltay, E. J., Gooren, L. J., & Saad, F. (2010) · hmbci · doi:10.1515/hmbci.2010.033 · Cited by 10
Chen, Q., Che, M., Shen, W., Shao, L., Yu, H., & Zhou, J. W. (2023) · American Journal of Men s Health · doi:10.1177/15579883231171462 · Cited by 9
“…is closely related to chronic inflammation, and testosterone affects the progression of atherosclerosis and related cardiovascular diseases by regulating vascular cells and immune cells in the process of inflammation (Kelly & Jones, 2013; Nettleship et al., 2007; Wilhelmson et al., 2018).”
BackgroundGagliano‐Jucá, T., Pencina, K. M., Shang, Y. V., Travison, T. G., Lincoff, A. M., Nissen, S. E., Artz, A. S., Li, X., Chan, A., Patel, R., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.04.004 · Cited by 11
Aminuddin, A., Salamt, N., Fuad, A. F. A., Chin, K., Ugusman, A., Soelaiman, I. N., & Ngah, W. Z. W. (2019) · Medicina · doi:10.3390/medicina55090575 · Cited by 7
Lokesh, S. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/21897.8523 · Cited by 7
Association of hair dye use with circulating levels of sex hormones in premenopausal Japanese women
Nagata, C., Wada, K., Tsuji, M., Hayashi, M., Takeda, N., & Yasuda, K. (2015) · European Journal of Public Health · doi:10.1093/eurpub/ckv020 · Cited by 6
Clinical Signs, Laboratory Diagnosis and Treatments Involved in Corona Viruses-19
Raoof, I. B., Okhti, Z. A., & Abdalah, M. E. (2022) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v21i1.776 · Cited by 6
Testosterone and cardiovascular disease
Channer, K. S., & Jones, T. H. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.011 · Cited by 5
Self-citationRole of Androgens in Cardiovascular Diseases in Men: A Comprehensive Review
Mukherjee, D., Sen, K., Gupta, S., Chowdhury, P. D., Majumder, S., & Guha, P. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.85852 · Cited by 5
Sarcopenia and non-alcoholic fatty liver disease - complex pathogenetic relationships
Ахмедов, В. А., & Marinenko, V. S. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-229-9-110-118 · Cited by 2
Gettler, L. T., Sarma, M. S., Gengo, R. G., Oka, R., & McKenna, J. J. (2019) · American Journal of Human Biology · doi:10.1002/ajhb.23248 · Cited by 2
Testosterone replacement and cardiovascular disease risk: what do endocrinologists need to know?
Gonzalez, J. R., & Goldstein, I. (2015) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000051 · Cited by 2
Antyukh, K. Y., Григоренко, Е. А., Sheptulina, A. F., Drapkina, O. M., & Митьковская, Н. П. (2023) · Кардиология в Беларуси · doi:10.34883/pi.2023.15.4.007 · Cited by 1
Monocyte to HDL-Cholesterol Ratio in Male with Hypogonadotropic Hypogonadism
Çadırcı, K., Oğuz, İ. S., Usta, T., Keskin, H., Çarlıoğlu, A., & Durmaz, Ş. A. (2019) · Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi · Cited by 2
Endocrinological Aspects of Atherosclerosis
Freudenberger, T., & Fischer, J. W. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0338-8_28
Faraday, N. R., & Dobs, A. S. (2014)
Benefits and Risks of Testosterone Replacement in the Older Man with Hypogonadism
Marcelli, M., & Mediwala, S. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-99918-6_30
Balakrishna, D., Sowjanya, B., Prasad, M., & Viswakumar, R. (2023) · Gene Reports · doi:10.1016/j.genrep.2023.101748
Late-Onset Hypogonadism: Pathophysiology and Diagnosis
Rastrelli, G. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_27
Ilchenko, L. Y., Ахмедов, В. А., Vinnitskaya, E. V., Иванович, Д. Е., Myazin, R. G., Nikitin, I. G., Tikhomirova, A. S., Khoroshilov, I., Myazin, R. G., Александровна, Э. О., et al. (2026) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-236-4-3-36
Metadata
- Authors
- Nettleship, J., Pugh, P., Channer, K., Jones, T., & Jones, R.
- Affiliations
- University of Sheffield (GB)
- ORCID
- Nettleship, J.
- Venue
- Hormone and Metabolic Research
- Publisher
- Georg Thieme Verlag KG
- Published
- 2007-05
- Volume
- 39
- Issue
- 5
- Pages
- 366-371
- ISSN
- 0018-5043 (ISSN-L)
- 1439-4286
- OpenAlex
- W2049482927
- Cited by
- 73
- References
- 0
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 7 · 2019: 7 · 2018: 3 · 2017: 1 · 2016: 2 · 2015: 8 · 2014: 5 · 2013: 3 · 2012: 5
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hormone and Metabolic Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- IL-1β, testosterone, stable coronary artery disease, hypogonadism, IL-10, inflammatory cytokines, atherosclerosis, TNF-α, interleukin-6, men
- MeSH terms
- Aged, Coronary Artery Disease, Humans, Hypogonadism, Male, Middle Aged, Testosterone, Tumor Necrosis Factor-alpha, Interleukin-6, Interleukin-10, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.